Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Comment by EyeOnThePryzeon Jan 19, 2021 3:52pm
180 Views
Post# 32328801

RE:RE:Thanku for making my case; TC is SELLING & Lots left to sell

RE:RE:Thanku for making my case; TC is SELLING & Lots left to sellDiagnos is NOT a pharma business, it is a technology business that supports the sales of Pharma products. I like Diagnos technology, the advantage over competition is the AI database that has been trained. Other than the guarded AI algos, Diagnos is nothing special. An AI database by competition can be replicated over time to do effectively the same thing with a sample size of ~100,000 by anyone. Its difficult to quantify matters, I wish you all the best of luck. I just question why people are so defensive about Mr. Coffin doing what can only be interpreted as a clearly negative move. Pointing out he only got rid of 2.5% is NOT a good thing, it means he has lots more to get rid of. Stop the nonsense.
<< Previous
Bullboard Posts
Next >>